Researchers use iPS cells to produce hematopoietic stem cells

05/16/2013 | Mainichi (Japan), The

Researchers in Japan said they were able to create hematopoietic stem cells from induced pluripotent stem cells. The method involved inducing benign tumors in mice using iPS cells and then adding catalysts to trigger the formation of blood-producing stem cells. The team hopes to develop a method for creating cells that does not rely on the use of tumors.

View Full Article in:

Mainichi (Japan), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC